Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile 
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
Instagram Outage Disrupts Thousands of U.S. Users 
MESOPOTAMIA, Ohio, April 19, 2016 -- An article in the Sunday Review section of the January 17 issue of The New York Times ("How Measurement Fails Doctors and Teachers") described the current fervor regarding outcomes measurement and accountability as possibly jeopardizing the quality of health care and education in the United States. However, the Times states, "We need more targeted measures, ones that have been vetted to ensure they really matter."
"At Hopewell, that vetting process is paramount," said Karges, Executive Director/CEO of Hopewell. "Since 2006, Hopewell has gathered and accessed data regarding the effectiveness of its programs and their impact on the recovery of its residents."
Hopewell's Outcomes Measurement Team is led by Candace Carlton, LISW-S, Quality Improvement and Compliance Director, and Sherry Bacon-Graves, BA, Outcomes Coordinator. The team also includes Sana Loue, PhD, MSSA, MA, JD, Hopewell's Research Consultant from Case Western Reserve University. Dr. Loue meets regularly with Carlton and Bacon-Graves, providing training on research techniques and the most effective methods of data analysis.
This team works with the Research Committee of Hopewell's board of directors to gather, analyze and report the periodic systematic measurements of each resident's progress as well as the effectiveness of each of Hopewell's programs as evidenced by the residents' progress, according to Karges. Over 70% of Hopewell residents have moved successfully into more self-reliant settings.
"Our outcomes measurement results show clearly that the Hopewell Model of care is effective," Karges continued. "The results lead us to improvement and may lead to programmatic changes. Often, the results indicate the need to replace older measurement tools with newer ones or to create customized tools as new programs are developed."
For more information about Hopewell's outcomes measurement and research, and to read the outcomes report, visit www.hopewellcommunity.org/files/news/2013outcomesreportrevised.pdf.
About Hopewell
Hopewell is a 300-acre residential working farm located in Mesopotamia, Ohio, where adults with schizophrenia, bipolar disorder and major depression learn to manage their mental illness and return to independent life. Hopewell is the only therapeutic farm community in Ohio. It is ODMHAS-licensed and CARF-accredited. Hopewell is a member of the National Alliance on Mental Illness and the American Residential Treatment Association.
Information and assessments are available by contacting Daniel Horne, director of admissions, at 440.426.2009. Visit www.hopewellcommunity.org.
CONTACT: Ed Stevens
440.617.0100 ext. 201
[email protected]
